ADVFN - ニュース

S&P 500

5,751.07

0.90%

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:BBAAY	Alibaba Group Holding Ltd (PK)
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SDOT	Sadot Group Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMBL	Bumble Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TPX	Tempur Sealy International Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXZ	iPath Series B S&P 500 VIX MidTerm Futures ETN
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACMR	ACM Research Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARAY	Accuray Incorporated
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	AMEX:UMAC	Unusual Machines Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SDOT	Sadot Group Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TPX	Tempur Sealy International Inc
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTEM	Molecular Templates Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCTY	Paylocity Holding Corporation
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VMAR	Vision Marine Technologies Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:HUMAW	Humacyte Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ARAY	Accuray Incorporated
2024/10/05	05 : 01	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:BOWNU	Bowen Acquisition Corporation
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SDOT	Sadot Group Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FDUS	Fidus Investment Corporation
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	USOTC:SAML	Samsara Luggage Inc (PK)
2024/10/05	05 : 01	GlobeNewswire Inc.	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ANIK	Anika Therapeutics Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:VVPR	VivoPower International PLC
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NAAS	NaaS Technology Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYTO	Altamira Therapeutics Ltd
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QUBT	Quantum Computing Inc
2024/10/05	05 : 01	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:FRST	Primis Financial Corporation
2024/10/05	05 : 01	Business Wire	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/10/05	05 : 01	Business Wire	Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc